|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1989-11-22
|
|
pubmed:abstractText |
Three different proliferation-associated monoclonal antibodies have been studied immunohistochemically to evaluate their prognostic value in patients with squamous cell carcinomas of head and neck. The monoclonal antibody Ki 67 shows a heterogeneous distribution pattern, whereas epidermal growth factor receptor and transferrin receptor expression show a homogeneous one. Concluding from our results the chances to use the described monoclonal antibodies as prognostic markers are limited.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0001-6497
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
43
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
41-6
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:2801095-Antibodies, Monoclonal,
pubmed-meshheading:2801095-Antigens, Nuclear,
pubmed-meshheading:2801095-Autoantigens,
pubmed-meshheading:2801095-Carcinoma, Squamous Cell,
pubmed-meshheading:2801095-Head and Neck Neoplasms,
pubmed-meshheading:2801095-Humans,
pubmed-meshheading:2801095-Immunohistochemistry,
pubmed-meshheading:2801095-Nuclear Proteins,
pubmed-meshheading:2801095-Prognosis,
pubmed-meshheading:2801095-Receptor, Epidermal Growth Factor,
pubmed-meshheading:2801095-Receptors, Transferrin
|
|
pubmed:year |
1989
|
|
pubmed:articleTitle |
Proliferation-associated monoclonal antibodies: a useful tool for prognosis in squamous cell carcinomas of head and neck?
|
|
pubmed:affiliation |
Zentrum der Hals-Nasen-Ohrenheilkunde der Johann Wolfgang-Goeth Universität Frankfurt/Main, FRG.
|
|
pubmed:publicationType |
Journal Article
|
